Alaric Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.25 M
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 4.95%
- Profit Growth -78.58%
- Ebitda 304.72%
- Net Worth 0.49%
- Total Assets 22.50%
About Alaric Life Sciences
Alaric Life Sciences Private Limited (ALSPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 June 2018 (Six years and seven months 30 days old ). Its registered office is in Sirmaur, Himachal Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.25 M, as per Ministry of Corporate Affairs (MCA) records.
Sham Lal, Sangram, and Yogita Kumari serve as directors at the Company.
Company Details
-
Location
Sirmaur, Himachal Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999HP2018PTC007047
-
Company No.
007047
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Jun 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Himachal Pradesh
Industry
Who are the key members and board of directors at Alaric Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sham Lal
|
Director | 08-Jun-2018 | Current |
|
Sangram
|
Director | 08-Jun-2018 | Current |
|
Yogita Kumari
|
Director | 08-Jun-2018 | Current |
Financial Performance of Alaric Life Sciences.
Alaric Life Sciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.95% increase. The company also saw a substantial fall in profitability, with a 78.58% decrease in profit. The company's net worth moved up by a moderate rise of 0.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alaric Life Sciences?
In 2023, Alaric Life Sciences had a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Symbiosis Life Sciences LimitedSham Lal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Alaric Life Sciences?
Unlock and access historical data on people associated with Alaric Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alaric Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alaric Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.